Collaborate Disseminate
Researchers in Japan have demonstrated a promising new cancer treatment. The team developed artificial DNA sequences shaped like hairpins that latch onto molecules overexpressed in cancer and trigger a strong immune response.Continue ReadingCategory: M… Continue reading “Hairpins” made of artificial DNA clasp and kill cancer
A combination of immunotherapy and chemotherapy has shown promise for treating stage IV melanoma in a new clinical trial. The chemo drug targets a type of cell that suppresses the immune response, and together the two showed an increased response rate…. Continue reading Immunotherapy-boosting chemo drug shows promise in clinical trial
A new study from researchers in Japan offers the first direct investigation into the effects of caffeine on 100-meter sprint running. The findings revealed athletes who dose up on caffeine can run significantly faster sprint times.Continue ReadingCateg… Continue reading Sprint study confirms caffeine does help you run faster
Immunotherapy is a promising cancer treatment, but getting it to work against solid tumors is proving difficult. A new study has not only identified a drug that’s effective against solid tumors, but may have uncovered a reason that immunotherapy often … Continue reading Promising prostate cancer drug hints at improved immunotherapy
The US Food and Drug Administration (FDA) has approved the first drug that can delay the onset of type 1 diabetes. A recent trial has shown that the drug, named teplizumab, can give patients several extra disease-free years.Continue ReadingCategory: Me… Continue reading First drug that delays onset of type 1 diabetes approved by FDA
Drugs given to the whole body can be too much of a shotgun approach, damaging cells that aren’t meant to be targeted. A new study has found that cloaking drugs inside red blood cells could help guide powerful but toxic antibiotics to target bacteria.Co… Continue reading Modified blood cells deliver antibiotics to kill dangerous bacteria
Urinary tract infections (UTIs) are common and treatable, but there can be complications, especially when the bacteria become drug resistant. Now, a new drug combo has shown promise in a Phase 3 clinical trial.Continue ReadingCategory: Medical, Science… Continue reading Combo therapy clinical trial shows promise against drug-resistant UTIs
Scientists at the University of California San Francisco (UCSF) have found a way to fight one of the most common cancer-causing mutations. The new drug puts up an “eat me” marker that can help the immune system or other drugs find and kill the cancer.C… Continue reading Immunotherapy combo targets mutation found in up to 25% of all cancers
Small cell lung cancer (SCLC) is one of the deadliest forms of the disease, but now scientists may have a promising new avenue for treatment. By combining a new drug with an outdated one, the team found that they could halt growth of tumors in mice.Con… Continue reading Experimental drug combo halts growth of deadly lung cancer in mice
Small cell lung cancer (SCLC) is one of the deadliest forms of the disease, but now scientists may have a promising new avenue for treatment. By combining a new drug with an outdated one, the team found that they could halt growth of tumors in mice.Con… Continue reading Experimental drug combo halts growth of deadly lung cancer in mice